RJA
BRLI

Raymond James & Associates’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Raymond James & Associates’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-54,709
Closed -$1.57M – 2033
2013
Q2 		$1.57M Buy
+54,709
New +$1.51M 0.01% 934

Other funds holding BRLI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Raymond James & Associates's BRLI Position: Q3 2013 in Review

Raymond James & Associates sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2013, closing a stake of 54,709 shares — an estimated $1.57M sold.

Raymond James & Associates first reported a position in BRLI in Q2 2013 and held it in 1 quarter. The position peaked at $1.57M in Q2 2013. 175 funds tracked by Wall St. Rank hold BRLI as of Q3 2013.

  • Raymond James & Associates reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2013 after selling out during the quarter.
  • Raymond James & Associates sold 54,709 BIO-REFERENCE LABS INC-NEW- shares in Q3 2013, an estimated $1.57M.
  • Raymond James & Associates first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 1 quarter.
  • Raymond James & Associates's BIO-REFERENCE LABS INC-NEW- position peaked at $1.57M in Q2 2013.
  • 175 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2013.

Based on Raymond James & Associates's 13F filing for Q3 2013, filed 13 Nov 2013.